Contents



Preface

Dyslipidemia is a major risk factor for cardiovascular events, cardiovascular mortality, and all-cause mortality. The earlier in life dyslipidemia is treated, the better the prognosis. Treatment of dyslipidemia should follow the recommendations of the American Heart Association/American College of Cardiology lipid guidelines published in Circulation 2019; 139: e1046-e1081, and the recommendations of the European Society of Cardiology/European Atherosclerosis Society

The current book is an excellent one on dyslipidemia written by experts on this topic. This book includes 12 chapters including 5 on lipids, 4 on hypercholesterolemia in children, and 3 on the treatment of dyslipidemia. This book should be read by all health care professionals taking care of patients, including pediatricians since

I would like to thank all the contributors to this book for their excellent chapters. I would also like to thank Jasna Božić, the author service manager from IntechOpen,

> **Wilbert S. Aronow, MD, FACC, FAHA, FASPC, FACP** Professor of Medicine and Director of Cardiology Research,

> > Department of Cardiology, Westchester Medical Center, New York Medical College,

> > > Valhalla, NY, USA

published in the European Heart Journal 2020; 41: 111-188.

atherosclerotic cardiovascular disease begins in childhood.

for her excellent assistance in editing this book.
